Cointime

Abcam

company

About

An innovator in life science reagents and tools serving life science researchers globally to achieve their mission, faster.

  • 1001 - 5000

Highlights

Total Funding Amount
£200M
Funding Rounds
1
Investors
1
Investments
2

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
£200M
Industries
Biotechnology,Life Science
Founded date
Jan 1, 1998
Number Of Employee
1001 - 5000
Operating Status
Active

As an innovator in reagents and tools, our purpose is to serve life science researchers globally to achieve their mission, faster.

Two-thirds of the world’s 750,000 life science researchers use Abcam’s affinity binders, reagents, biomarkers and assays.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
£200M
Abcam has raised a total of £200M in funding over 2 rounds. Their latest funding was raised on May 15, 2019 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 15, 2019 Post-IPO Equity £200M 1 HSBC — Detail

Investments

Number of Investments
Number of Lead Investments
2
0
Abcam has made 2 investments. Their most recent investment was on Jul 10, 2014, when Button raised $2.25M.
Date Company Name
Round Money Raised Industry Lead Investor
Jul 10, 2014 Button
Seed $2.25M Enterprise Software —
May 14, 2013 Ripple
Seed $1.40M Blockchain —

Investors

Number of Lead Investors
Number of Investors
1
1
Abcam is funded by 1 investors. HSBC are the most recent investors.
Investor Name Lead Investor Funding Round
HSBC Yes Post-IPO Equity
Cointime
เนื้อหา
บริษัท